A delegation from Taiwan is showcasing cutting-edge biomedical products and innovative technologies at the BIO International Convention June 3-6 at southern California’s San Diego Convention Center, according to the Ministry of Economic Affairs.

Officials from the MOEA, the Ministry of Agriculture, the Ministry of Health and Welfare, the National Development Council, the National Science and Technology Council, Taipei City Government and the capital-based National Biotechnology Research Park make up the delegation. It also includes around 230 experts and representatives from over 80 businesses and institutions.

Visitors to the Taiwan pavilion can learn about new drugs and innovative biotechnology, including organs-on-chips and customized tumor clones for targeted testing. Smart medical solutions like rapid screening for high-risk neurological diseases and artificial intelligence-assisted physiological monitoring, as well as new developments in regenerative medicine are also on display.

Ten pharmaceutical factories show off their small molecule drugs and biologics in the pavilion’s section for contract development and manufacturing organizations, and six biotech and pharmaceutical research institutions such as Academia Sinica exhibit their achievements in areas spanning agricultural biotechnology and medical equipment.

In his remarks at the opening of the pavilion, Chen Pei-li, deputy director general of the MOEA’s Industrial Development Administration, said that integrating technologies across fields is an industry trend. Taiwan is well suited to collaborating with other countries to provide better products and services on the strength of its advanced information and communications technology, complete supply chains and outstanding clinical care, he added.

According to the MOEA, five Taiwan enterprises were shortlisted for the conference’s Start-Up Stadium, which provides opportunities for engagement with investors, while Taipei-headquartered Taiwan Bio Industry Organization introduced the country’s relevant development during the Global Innovation Hub business matchmaking session.

To further strengthen connections with the U.S. biotech sector, MOEA officials visited institutions including Barrow Neurological Institute and Mayo Clinic May 30-31 in Phoenix, and has plans to call on factories like Tanvex BioPharma Inc. after the conference, the ministry added. (YCH-E)

Taiwan today